PA HB1365

Establishes the Medication-Induced Movement Disorders Screening Education Program within the Pennsylvania Department of Health to educate residents and healthcare providers about neurological conditions caused by prolonged use of mental health medications

Requires the Department of Health to develop the program in consultation with the Office of Developmental Programs, Office of Mental Health and Substance Abuse Services, Department of Aging, Department of Drug and Alcohol Programs, and Bureau of Community Corrections

Mandates development of guidance and educational materials for healthcare providers on clinical standards and best practices for screening and treatment, informed by American Psychiatric Association guidelines and applicable to telehealth services

Requires creation of electronic informational materials to be posted on the Department of Health website and distributed to healthcare providers and facilities serving high-risk populations

Includes public education and outreach to reduce stigma for individuals with medication-induced movement disorders, including awareness materials for public safety officers; takes effect 60 days after enactment